Market Overview

Sterne Agee Initiates Boston Scientific At Neutral

Related BSX
Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device
Benzinga's Top Initiations
Do Not Strike Stryker Out (Seeking Alpha)

Sterne Agee initiated coverage on shares of Boston Scientific (NYSE: BSX) with a Neutral rating.

The target price for Boston Scientific is set to $13.50.

Boston Scientific shares have surged 19.76% over the past 52 weeks, while the S&P 500 index has gained 17.38% in the same period.

Boston Scientific's shares dropped 1.07% to close at $12.97 yesterday.

Latest Ratings for BSX

Nov 2015CitigroupInitiates Coverage onBuy
Oct 2015BarclaysMaintainsOverweight
Oct 2015Raymond JamesDowngradesOutperformStrong Buy

View More Analyst Ratings for BSX
View the Latest Analyst Ratings

Posted-In: Sterne AgeeInitiation Analyst Ratings


Related Articles (BSX)

View Comments and Join the Discussion!

Get Benzinga's Newsletters